A group of investors led by the venture capital group, Inventages, has raised €7 million in a Series B funding round for Phagenesis Ltd, the developer of a medical device for dysphagia, a condition that affects a patient’s ability to swallow. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals